Birdwatch Note Rating
2024-04-29 06:29:09 UTC - HELPFUL
Rated by Participant: F84822F502E92F069659B7E05DBE49E5DF05899B154FF6E9E3455E102EBAC6CE
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 53% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://nejm.org/doi/full/10.1056/nejmoa1910993 https://paho.org/en/topics/ebola-virus-disease
All Note Details